Multifunctionalized Microalgae (MM) - A novel and flexible platform technology for maximising feed/energy conversion ratios and treating severe infections in livestock
Lead Participant:
AMALGA TECHNOLOGIES LIMITED
Abstract
Production-purpose antibiotics are one of the great Faustian bargains of the modern era: mankind has traded
increased livestock yields today for AMR tomorrow. We propose that microalgae can be readily engineered to
express a wide range of naturally occurring antimicrobial and anti-inflammatory compounds which can both
substitute for production-purpose antibiotics as a means of maximizing feed/energy conversion ratios and treat
serious bacterial infections. Our objective in this project is to unequivocally demonstrate this using multi-
functionalized microalgae (MM) modified to accumulate two such agents in a series of rigorous field-trials in
both healthy and E.coli (K99)-infected calves. Our project is innovative in that MM can not only express these &
numerous other functional biochemical compounds, but also constitute a uniquely low-cost and practicable
platform technology. 350 million Chinese still live on less than $3/day and microalgae is the only combined
expression/delivery system capable of synthesizing the full range of bioactive agents required for managing the
complexity of intestinal flora which can be cultivated by both industrial-scale and LMIC artisanal farmers alike.
increased livestock yields today for AMR tomorrow. We propose that microalgae can be readily engineered to
express a wide range of naturally occurring antimicrobial and anti-inflammatory compounds which can both
substitute for production-purpose antibiotics as a means of maximizing feed/energy conversion ratios and treat
serious bacterial infections. Our objective in this project is to unequivocally demonstrate this using multi-
functionalized microalgae (MM) modified to accumulate two such agents in a series of rigorous field-trials in
both healthy and E.coli (K99)-infected calves. Our project is innovative in that MM can not only express these &
numerous other functional biochemical compounds, but also constitute a uniquely low-cost and practicable
platform technology. 350 million Chinese still live on less than $3/day and microalgae is the only combined
expression/delivery system capable of synthesizing the full range of bioactive agents required for managing the
complexity of intestinal flora which can be cultivated by both industrial-scale and LMIC artisanal farmers alike.
Lead Participant | Project Cost | Grant Offer |
---|---|---|
AMALGA TECHNOLOGIES LIMITED | £189,841 | £ 132,889 |
  | ||
Participant |
||
ROTHAMSTED RESEARCH | £319,772 | £ 319,772 |
UNIVERSITY OF EXETER | £19,276 | £ 19,276 |
MOREDUN RESEARCH INSTITUTE | £68,010 | £ 68,010 |
PLYMOUTH MARINE LABORATORY | £186,525 | £ 186,525 |
People |
ORCID iD |
Paul Goddard (Project Manager) |